Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,360.56
1,307.54
1,195.25
1,153.86
1,146.54
956.74
843.29
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,360.56
1,307.54
1,195.25
1,153.86
1,146.54
956.74
843.29
Raw Material Cost
813.13
784.08
680.26
689.08
642.75
513.01
454.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.75
22.77
16.35
9.15
2.67
2.71
2.29
Selling and Distribution Expenses
320.41
305.91
300.74
293.61
275.97
248.41
253.10
Other Expenses
10.50
8.01
8.41
8.53
8.94
7.07
6.75
Total Expenditure (Excl Depreciation)
1,257.34
1,192.83
1,081.47
1,077.14
1,010.75
834.79
777.06
Operating Profit (PBDIT) excl Other Income
103.2
114.7
113.80000000000001
76.7
135.8
122
66.2
Other Income
27.51
34.74
34.42
40.20
46.38
29.35
37.08
Operating Profit (PBDIT)
232.87
260.29
212.99
181.03
227.51
185.90
137.06
Interest
18.75
22.77
16.35
9.15
2.67
2.71
2.29
Exceptional Items
29.66
6.60
4.91
-1.38
-1.18
-0.30
0.69
Gross Profit (PBDT)
547.43
523.46
514.99
464.78
503.80
443.74
389.12
Depreciation
118.24
112.19
74.28
66.66
51.90
43.09
37.96
Profit Before Tax
125.54
131.93
127.27
103.85
171.76
139.81
97.50
Tax
26.24
31.27
19.64
16.78
21.31
17.84
8.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.81
62.64
80.71
69.84
132.57
108.98
77.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.81
62.64
80.71
69.84
132.57
108.98
77.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
27.66
29.53
22.15
15.57
17.52
13.33
11.64
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
97.47
92.17
102.86
85.41
150.10
122.30
89.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,782.52
1,737.72
1,708.29
1,644.69
1,604.52
1,034.12
962.18
Earnings per share (EPS)
0.28
0.25
0.32
0.27
0.54
0.5
0.36
Diluted Earnings per share
0.28
0.25
0.32
0.27
0.54
0.5
0.36
Operating Profit Margin (Excl OI)
6.4%
8.67%
8.73%
6.43%
11.27%
11.86%
7.35%
Gross Profit Margin
17.92%
18.67%
16.86%
14.78%
19.51%
19.12%
16.06%
PAT Margin
5.13%
4.79%
6.75%
6.05%
11.56%
11.39%
9.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 4.06% vs 9.39% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 5.75% vs -10.40% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -8.95% vs 26.32% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -17.54% vs 39.88% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Qingdao Vland Biotech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,360.56
0
1,360.56
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,360.56
0
1,360.56
Raw Material Cost
813.13
0
813.13
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
18.75
0
18.75
Selling and Distribution Expenses
320.41
0
320.41
Other Expenses
10.50
0.00
10.50
Total Expenditure (Excl Depreciation)
1,257.34
0
1,257.34
Operating Profit (PBDIT) excl Other Income
103.22
0.00
103.22
Other Income
27.51
0
27.51
Operating Profit (PBDIT)
232.87
0
232.87
Interest
18.75
0
18.75
Exceptional Items
29.66
0
29.66
Gross Profit (PBDT)
547.43
0
547.43
Depreciation
118.24
0
118.24
Profit Before Tax
125.54
0
125.54
Tax
26.24
0
26.24
Provisions and contingencies
0
0
0.00
Profit After Tax
69.81
0
69.81
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
69.81
0
69.81
Share in Profit of Associates
0
0
0.00
Minority Interest
27.66
0
27.66
Other related items
0.00
0.00
0.00
Consolidated Net Profit
97.47
0
97.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,782.52
0
1,782.52
Earnings per share (EPS)
0.28
0
0.28
Diluted Earnings per share
0.28
0
0.28
Operating Profit Margin (Excl OI)
6.40%
0%
0.00
6.40%
Gross Profit Margin
17.92%
0%
0.00
17.92%
PAT Margin
5.13%
0%
0.00
5.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 136.06 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 4.06% vs 9.39% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 9.75 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.75% vs -10.40% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.54 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -8.95% vs 26.32% in Dec 2024
Annual - Interest
Interest 1.88 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -17.54% vs 39.88% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.40%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






